- First Watch Restaurant 2Q Same-Restaurant Sales Growth of 3.4% >FWRG
- Timken Raises FY View To Adj EPS $6.05-Adj Loss/Shr $6.35 >TKR
- Intensifying market competition combined with weak consumer confidence! Automotive and luxury sectors become Europe's financial reporting season "drag factors"
- First Watch Restaurant 2Q Net $2.3M >FWRG
- Rockwell Automation Sees FY26 Reported, Organic Sales Up 7.5%-9.5% >ROK
- BellRing Brands 3Q Sales $570.4M >BRBR
- Analyst Says $10+ XRP Price Is No Longer A Wild Target, But…
- McDonald's 2Q Revenue from Franchised Restaurants $4.39B >MCD
- Knife River 2Q Rev $938.6M >KNF
- McDonald's 2Q EPS $3.32 >MCD
- McDonald's 2Q Sales by Company-Owned and Operated Restaurants Up 3% >MCD
- McDonald's 2Q Sales by Company-Owned and Operated Restaurants $2.53B >MCD
- McDonald's 2Q Global Comp Sales Up 1.3% >MCD
- McDonald's 2Q Adj EPS $3.38 >MCD
- AdaptHealth 2Q Loss/Shr 99c >AHCO
- Larimar Therapeutics 2Q Loss $32.8M >LRMR
- Rockwell Automation 3Q EPS $3.65 >ROK
- Rockwell Automation 3Q Adj EPS $3.49 >ROK
- Rockwell Automation 3Q Net $408M >ROK
- The Hartford To Acquire Equitable's Employee Benefits Business >HIG
- UL Solutions 2Q Net $246M >ULS
- UL Solutions 2Q Rev $816M >ULS
- Wayfair 2Q Active Customers 21.7M >W
- Wayfair 2Q Loss/Shr 1c >W
- Knife River Sees FY Rev $3.4B-$3.6B >KNF
- McDonald's Systemwide Sales to Loyalty Members $40B for Trailing 12 Months, Across 70 Loyalty Markets >MCD
- McDonald's 2Q International Developmental Licensed Markets Segment Comp Sales Rose 1.9% >MCD
- McDonald's 2Q U.S. Comparable Sales Results Were Primarily Driven by Positive Check Growth >MCD
- McDonald's 2Q International Operated Markets Comp Sales Reflect Positive Comparable Sales in Most Markets, Led by Germany, Australia and the UK, Partly Offset by France >MCD
- McDonald's 2Q International Developmental Licensed Markets Positive Comp Sales Were Led by Japan, With All Geographic Regions Reflecting Positive Comp Sales >MCD
- McDonald's: Delivered Positive Comparable Sales Growth Across Every Segment in 2Q and Acted Decisively to Strengthen Execution as We Prime McDonald's for Next Era of Long-Term Growth >MCD
- McDonald's 90-Day Active Loyalty Users Up 13% to Nearly 220M as of 2Q-End >MCD
- McDonald's: Skye Anderson Appointed President of McDonald's USA to Lead Co's Largest Market >MCD
- Beam Therapeutics 2Q Loss/Shr $1.18 >BEAM
- McDonald's 2Q International Operated Markets Segment Comp Sales Rose 1.5% >MCD
- McDonald's 2Q Results Include Pretax Charges of $52M Primarily Related to Restructuring Charges Associated With CO's Accelerating the Organization >MCD
- Beam Therapeutics 2Q Loss $122.7M >BEAM
- Rockwell Automation Sees FY Adj EPS $13.00-Adj EPS $13.30 >ROK
- Rockwell Automation Sees FY EPS $12.72-EPS $13.02 >ROK
- McDonald's 2Q Global Systemwide Sales Rose 5% >MCD
- McDonald's 2Q Revenue from Franchised Restaurants Up 4% >MCD
- Rockwell Automation 3Q Sales $2.31B >ROK
- McDonald's 2Q U.S. Comp Sales Up 0.8% >MCD
- Micron’s production capacity sold out through 2027, analysts say
- Entering the window to break the previous high for the third time, can Good Future (TAL.US) deliver a good stock price with good results?
- Spot gold has just broken through the $4060.00 per ounce mark, now quoted at $4060.03 per ounce, up 0.12% on the day; the main COMEX gold futures contract is now quoted at $4115.90 per ounce, up 0.62% on the day.
- US crude oil continuous contract plunged by $1.28 per barrel in the short term, hitting a low of $80.61 per barrel. Brent crude oil dropped $1.33 per barrel in the short term, hitting a low of $84.33 per barrel, as Qatar stated that a draft text has been prepared for a possible US-Iran agreement.
- Pfizer reports second quarter revenue of $15.03 billion, compared to an estimate of $14.41 billion. Adjusted earnings per share for the second quarter are $0.77. Pfizer expects full-year revenue between $60.5 billion and $62.5 billion, with the market estimate at $61.76 billion.
- The main contract of Nymex crude oil futures has just surpassed the $81.00 per barrel mark, with the latest quote at $80.99 per barrel, up 0.81% on the day.
- Brent crude oil futures have just surpassed the $85.00 per barrel mark, currently quoted at $84.98 per barrel, up 1.74% on the day.
- Ametek 2Q EPS $1.77 >AME
- Aptiv Sees 3Q Adjusted Ebitda $545M-$575M >APTV
- Scotts Miracle-Gro: Continue to Make Significant, Meaningful Progress on Core Elements of SMG 2.0, Putting Us on Clear Path to Meet or Exceed Fincl Commitments We Established for Fiscal 2026 >SMG
- Ametek 2Q Sales $2.04B >AME
- Ametek 2Q Net $406.9M >AME
- Ametek 2Q Adj EPS $2.09 >AME
- Aptiv Sees 2026 Adjusted Ebitda $2.31B-$2.37B >APTV
- Wheels Up Experience 2Q Rev $182M >UP
- AAVE holds above $90 as protocol deposits rise, but retail demand weakens
- Kimco Realty 2Q FFO 46c/Shr >KIM
- Kimco Realty 2Q Net $153.3M >KIM
- Kimco Realty Sees FY EPS $1.00-EPS $1.03 >KIM
- Cardano (ADA) Price Eyes Breakout as Bulls Challenge Key Resistance Near $0.22
- ATOM Price Leads DeFi Rally as Traders Bet on Cosmos Recovery
- Pfizer: Current 2026 Financial Guidance Doesn't Anticipate Any Stock Buybacks >PFE
- U.S. stocks move丨Zebra Technologies rises over 11% in pre-market trading
- Pfizer 2Q Loss Reflects $4.3 Billion in Non-Cash Intangible Asset Impairments >PFE
- Pfizer Sets $2.5 Billion Additional Anticipated Productivity Enhancement Savings Associated With Ongoing Initiatives >PFE
- UBS Group: Adidas target price lowered from 219 euros to 173 euros.
- Pfizer 2Q Revenue Rose 5% Operationally Excluding Contributions From Comirnaty, Paxlovid >PFE
- US ISM Manufacturing PMI Hits 4-Year High; Stock and Crypto Markets Eye Rally
- Marathon Petroleum 2Q EPS $17.73 >MPC
- Haverty Furniture 2Q Sales $194.9M >HVT
- Haverty Furniture 2Q Net $5.31M >HVT
- Marathon Petroleum 2Q Adj EPS $17.73 >MPC
- Pfizer Sees 2026 Rev $60.5B-$62.5B >PFE
- Haverty Furniture 2Q EPS 32c >HVT
- Snap Inc. Stock Jumps 5% on 19% Revenue Growth, Hits Key Resistance
- Kimberly-Clark 2Q EPS $1.04 >KMB
- Kimberly-Clark: 2026 Adj. EPS Attributable to Co Are Expected to See Low-Single-Digit Decline on Constant-Currency Basis >KMB
- Kimberly-Clark: 2026 Adj EPS From Cont Ops Expected to Grow High Single Digits on Constant-Currency Basis Including an About 30% Increase in Income From Equity Cos Vs Yr-Ago >KMB
- Kimberly-Clark: 2026 Adjusted Operating Profit Now Expected to Grow Mid-Single Digits on Constant-Currency Basis >KMB
- InfuSystem 2Q Rev $36.9M >INFU
- Chatham Lodging Trust 2Q Net $8.21M >CLDT
- Trex Co 2Q EPS 60c >TREX
- Enpro 2Q EPS $1.27 >NPO
- Westlake 2Q Sales $3.27B >WLK
- IDEXX Labs 2Q EPS $4.27 >IDXX
- Merck: MK-4208, Formerly TERN-701, Is Novel Investigational Oral Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor Recently Granted BTD by FDA for Treatment of Certain Adults With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia >MRK
- Kimberly-Clark Now Sees 2026 Organic Sales Growth to Be About 100 Basis Points Below Its Weighted Average Category Growth in Categories and Countries It Competes, Currently 2% on Trailing 12-Month Basis >KMB
- Kimberly-Clark 2Q Sales $4.19B >KMB
- Kimberly-Clark 2Q Adj EPS $2.12 >KMB
- Kimberly-Clark 2Q Cont Ops EPS $1.22 >KMB
- Kimberly-Clark 2Q Adj EPS From Cont Ops $1.80 >KMB
- Kimberly-Clark: 2Q Sales Rose 0.6% as Favorable Currency Impacts of 1.1% Were Partially Offset by Exit of CO's Private Label Diaper Business in US >KMB
- Kimberly-Clark 2Q Organic Sales Growth Broadly in Line With Prior Year >KMB
- Kimberly-Clark: Independent Testing Conducted by Government-Certified Third Party Confirmed Quality and Safety of Co's Products, Refuting the False Allegations >KMB
- Kimberly-Clark: Situation Expected to Further Impact Sales and Profit in Near Term >KMB
- Kimberly-Clark: 2Q North America Net Sales $2.7B, Down 1.2% >KMB
- Kimberly-Clark: 2Q North America Net Sales Includes 0.5% Impact From Exit of CO's Private Label Diaper Business in US >KMB
